National Peroxide Ltd is Rated Sell

Current Rating and Its Implications for Investors

MarketsMOJO currently assigns National Peroxide Ltd a 'Sell' rating, indicating a cautious stance towards the stock. This rating suggests that investors should consider reducing exposure or avoiding new purchases, given the company's present financial and market challenges. The 'Sell' recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Understanding these factors helps investors grasp why the stock is positioned as such and what it means for portfolio decisions.

Quality Assessment: Average Fundamentals Amidst Declining Growth

As of 04 April 2026, National Peroxide Ltd's quality grade is assessed as average. The company has struggled with poor long-term growth, evidenced by a negative compound annual growth rate (CAGR) of -12.60% in net sales over the past five years. Operating profit has deteriorated even more sharply, with a decline of -135.58% during the same period. These figures highlight persistent operational challenges and a lack of robust earnings growth, which weigh heavily on the company's quality score.

Valuation: Risky Terrain for Investors

The valuation grade for National Peroxide Ltd is classified as risky. The company is currently trading at valuations that are less favourable compared to its historical averages, reflecting investor concerns about its profitability and growth prospects. The latest data shows a negative EBIT of ₹-6.64 crores, signalling operational losses that undermine confidence in the stock’s value. This elevated risk profile suggests that the stock may not offer an attractive entry point for value-conscious investors at present.

Financial Trend: Positive Signals Amidst Profitability Challenges

Despite the negative operating profits, the financial grade is rated positive, indicating some encouraging aspects in the company’s financial trajectory. However, this positivity is tempered by the fact that profits have fallen by -113% over the past year, and the stock has delivered a one-year return of -36.93%. The negative trend in earnings and returns points to ongoing financial stress, although certain underlying metrics may show stabilisation or improvement, justifying a cautiously optimistic financial trend rating.

Technical Analysis: Mildly Bearish Momentum

From a technical perspective, National Peroxide Ltd is graded as mildly bearish. The stock’s recent price movements reflect downward pressure, with a 3-month return of -19.66% and a 6-month decline of -36.23%. The one-day gain of 2.00% on 04 April 2026 offers a slight reprieve but does not alter the broader negative momentum. This technical outlook suggests that the stock may continue to face resistance in the near term, reinforcing the 'Sell' rating.

Stock Performance Overview

Currently, the stock has underperformed key benchmarks such as the BSE500 over multiple time frames, including the last three years, one year, and three months. The year-to-date return stands at -19.34%, reflecting ongoing challenges in regaining investor confidence. These returns, combined with the company’s operational and financial difficulties, provide a comprehensive picture of why the stock is rated 'Sell' today.

What This Means for Investors

For investors, the 'Sell' rating on National Peroxide Ltd signals caution. The combination of average quality, risky valuation, a mixed financial trend, and bearish technical indicators suggests that the stock currently faces significant headwinds. Investors should carefully evaluate their exposure to this microcap commodity chemicals company and consider alternative opportunities with stronger fundamentals and more favourable market dynamics.

Contextualising the Rating Change

The 'Sell' rating was established on 06 February 2026, following an improvement from a previous 'Strong Sell' grade. This change reflected a 25-point increase in the Mojo Score, from 12 to 37, signalling a slight easing of concerns. However, the current analysis as of 04 April 2026 shows that despite this improvement, the stock remains under pressure with significant challenges to overcome. Investors should note that all financial metrics and returns discussed are current and not historical data from the rating change date.

Sector and Market Position

Operating within the commodity chemicals sector, National Peroxide Ltd is classified as a microcap company. This positioning often entails higher volatility and risk, which is evident in the stock’s performance and valuation metrics. The sector itself can be cyclical and sensitive to raw material prices and demand fluctuations, factors that may be contributing to the company’s recent struggles.

Summary of Key Metrics as of 04 April 2026

The stock’s recent returns include a 1-day gain of 2.00%, but longer-term returns remain negative: -3.25% over one week, -10.12% over one month, -19.66% over three months, and -36.23% over six months. The one-year return is -36.93%, underscoring the sustained downward trend. Operating profit remains negative at ₹-6.64 crores, and the company’s net sales have declined at an annual rate of -12.60% over five years. These figures collectively justify the current 'Sell' rating.

Investor Takeaway

Investors should approach National Peroxide Ltd with caution. The current 'Sell' rating reflects a comprehensive assessment of the company’s operational difficulties, valuation risks, and technical weakness. While some financial trends show potential for improvement, the overall outlook remains challenging. Portfolio managers and individual investors alike should weigh these factors carefully before considering any position in this stock.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →